BRIEF-Revolution Medicines And Summit <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Enter Into Clinical Collaboration To Evaluate Combinations Of Three Ras(On) Inhibitors With Ivonescimab In Ras Mutant TumorsRevolution Medicines Inc RVMD.O:
REVOLUTION MEDICINES AND SUMMIT THERAPEUTICS ENTER INTO CLINICAL COLLABORATION TO EVALUATE COMBINATIONS OF THREE RAS$(ON)$ INHIBITORS WITH IVONESCIMAB IN RAS MUTANT TUMORS
REVOLUTION MEDICINES INC - SUMMIT TO SUPPLY IVONESCIMAB, REVOLUTION MEDICINES TO SPONSOR STUDY
Source text: ID:nGNX8PWjNv
Further company coverage: RVMD.O
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。